249 related articles for article (PubMed ID: 19727407)
1. Chronic glucagon-like peptide-1 infusion sustains left ventricular systolic function and prolongs survival in the spontaneously hypertensive, heart failure-prone rat.
Poornima I; Brown SB; Bhashyam S; Parikh P; Bolukoglu H; Shannon RP
Circ Heart Fail; 2008 Sep; 1(3):153-60. PubMed ID: 19727407
[TBL] [Abstract][Full Text] [Related]
2. Letter by Nguyen and Doenst regarding article "Chronic glucagon-like peptide-1 infusion sustains left ventricular systolic function and prolongs survival in the spontaneously hypertensive, heart-failure prone rat".
Nguyen TD; Doenst T
Circ Heart Fail; 2009 May; 2(3):e1; author reply e2. PubMed ID: 19808332
[No Abstract] [Full Text] [Related]
3. Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure.
Liu Q; Anderson C; Broyde A; Polizzi C; Fernandez R; Baron A; Parkes DG
Cardiovasc Diabetol; 2010 Nov; 9():76. PubMed ID: 21080957
[TBL] [Abstract][Full Text] [Related]
4. Pre-treatment with glucagon-like Peptide-1 protects against ischemic left ventricular dysfunction and stunning without a detected difference in myocardial substrate utilization.
McCormick LM; Hoole SP; White PA; Read PA; Axell RG; Clarke SJ; O'Sullivan M; West NEJ; Dutka DP
JACC Cardiovasc Interv; 2015 Feb; 8(2):292-301. PubMed ID: 25700752
[TBL] [Abstract][Full Text] [Related]
5. Glucagon-like peptide-1 protects against ischemic left ventricular dysfunction during hyperglycemia in patients with coronary artery disease and type 2 diabetes mellitus.
McCormick LM; Heck PM; Ring LS; Kydd AC; Clarke SJ; Hoole SP; Dutka DP
Cardiovasc Diabetol; 2015 Aug; 14():102. PubMed ID: 26253538
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure.
Peterson JT; Hallak H; Johnson L; Li H; O'Brien PM; Sliskovic DR; Bocan TM; Coker ML; Etoh T; Spinale FG
Circulation; 2001 May; 103(18):2303-9. PubMed ID: 11342481
[TBL] [Abstract][Full Text] [Related]
7. The intestine responds to heart failure by enhanced mitochondrial fusion through glucagon-like peptide-1 signalling.
Naruse G; Kanamori H; Yoshida A; Minatoguchi S; Kawaguchi T; Iwasa M; Yamada Y; Mikami A; Kawasaki M; Nishigaki K; Minatoguchi S
Cardiovasc Res; 2019 Nov; 115(13):1873-1885. PubMed ID: 30629149
[TBL] [Abstract][Full Text] [Related]
8. Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts.
Zhao T; Parikh P; Bhashyam S; Bolukoglu H; Poornima I; Shen YT; Shannon RP
J Pharmacol Exp Ther; 2006 Jun; 317(3):1106-13. PubMed ID: 16489128
[TBL] [Abstract][Full Text] [Related]
9. Active metabolite of GLP-1 mediates myocardial glucose uptake and improves left ventricular performance in conscious dogs with dilated cardiomyopathy.
Nikolaidis LA; Elahi D; Shen YT; Shannon RP
Am J Physiol Heart Circ Physiol; 2005 Dec; 289(6):H2401-8. PubMed ID: 16024574
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular and metabolic effects of 48-h glucagon-like peptide-1 infusion in compensated chronic patients with heart failure.
Halbirk M; Nørrelund H; Møller N; Holst JJ; Schmitz O; Nielsen R; Nielsen-Kudsk JE; Nielsen SS; Nielsen TT; Eiskjaer H; Bøtker HE; Wiggers H
Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H1096-102. PubMed ID: 20081109
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the early stage of cardiac remodeling of spontaneously hypertensive heart failure rats using the quantitative 3-dimensional analysis provided by acipimox-enhanced FDG-PET.
Maskali F; Poussier S; Louis H; Boutley H; Lhuillier M; Thornton SN; Karcher G; Lacolley P; Marie PY
Int J Cardiovasc Imaging; 2014 Feb; 30(2):449-56. PubMed ID: 24384858
[TBL] [Abstract][Full Text] [Related]
12. The Protective Role of the Long Pentraxin PTX3 in Spontaneously Hypertensive Rats with Heart Failure.
Chen W; Zhuang YS; Yang CX; Fang ZC; Liu BY; Zheng X; Liao YY
Cardiovasc Toxicol; 2021 Oct; 21(10):808-819. PubMed ID: 34173191
[TBL] [Abstract][Full Text] [Related]
13. Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy.
Nikolaidis LA; Elahi D; Hentosz T; Doverspike A; Huerbin R; Zourelias L; Stolarski C; Shen YT; Shannon RP
Circulation; 2004 Aug; 110(8):955-61. PubMed ID: 15313949
[TBL] [Abstract][Full Text] [Related]
14. Differential cardiotoxicity in response to chronic doxorubicin treatment in male spontaneous hypertension-heart failure (SHHF), spontaneously hypertensive (SHR), and Wistar Kyoto (WKY) rats.
Sharkey LC; Radin MJ; Heller L; Rogers LK; Tobias A; Matise I; Wang Q; Apple FS; McCune SA
Toxicol Appl Pharmacol; 2013 Nov; 273(1):47-57. PubMed ID: 23993975
[TBL] [Abstract][Full Text] [Related]
15. Rosuvastatin added to standard heart failure therapy improves cardiac remodelling in heart failure rats with preserved ejection fraction.
Gómez-Garre D; González-Rubio ML; Muñoz-Pacheco P; Caro-Vadillo A; Aragoncillo P; Fernández-Cruz A
Eur J Heart Fail; 2010 Sep; 12(9):903-12. PubMed ID: 20601374
[TBL] [Abstract][Full Text] [Related]
16. GLP-1 Improves Diastolic Function and Survival in Heart Failure with Preserved Ejection Fraction.
Nguyen TD; Shingu Y; Amorim PA; Schenkl C; Schwarzer M; Doenst T
J Cardiovasc Transl Res; 2018 Jun; 11(3):259-267. PubMed ID: 29464655
[TBL] [Abstract][Full Text] [Related]
17. Eplerenone enhances cardioprotective effects of standard heart failure therapy through matricellular proteins in hypertensive heart failure.
Muñoz-Pacheco P; Ortega-Hernández A; Caro-Vadillo A; Casanueva-Eliceiry S; Aragoncillo P; Egido J; Fernández-Cruz A; Gómez-Garre D
J Hypertens; 2013 Nov; 31(11):2309-18; discussion 2319. PubMed ID: 24077250
[TBL] [Abstract][Full Text] [Related]
18. Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy.
Minhas KM; Saraiva RM; Schuleri KH; Lehrke S; Zheng M; Saliaris AP; Berry CE; Barouch LA; Vandegaer KM; Li D; Hare JM
Circ Res; 2006 Feb; 98(2):271-9. PubMed ID: 16357304
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis.
Weinberg EO; Schoen FJ; George D; Kagaya Y; Douglas PS; Litwin SE; Schunkert H; Benedict CR; Lorell BH
Circulation; 1994 Sep; 90(3):1410-22. PubMed ID: 8087951
[TBL] [Abstract][Full Text] [Related]
20. Long-term physiological T3 supplementation in hypertensive heart disease in rats.
Weltman NY; Pol CJ; Zhang Y; Wang Y; Koder A; Raza S; Zucchi R; Saba A; Colligiani D; Gerdes AM
Am J Physiol Heart Circ Physiol; 2015 Sep; 309(6):H1059-65. PubMed ID: 26254335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
